Waning Immunity Most Consistent With Recent Mumps Outbreaks

TUESDAY, Jan. 10, 2023 (HealthDay News) -- A waning immunity model is most consistent with recently observed resurgent outbreaks of mumps in countries with high vaccine coverage, according to a study published online Jan. 9 in the Proceedings of the National Academy of Sciences.
Noting that multiple countries with high vaccine coverage have experienced resurgent outbreaks of mumps, Deven V. Gokhale, from the Odum School of Ecology at the University of Georgia in Athens, and colleagues proposed two putative mechanisms of vaccine failure as driving observed trends: gradual waning of immunity and the introduction of novel viral genotypes capable of evading vaccinal immunity. A statistical likelihood-based hypothesis testing was conducted using a mechanistic transmission model on age-structured epidemiological, demographic, and vaccine uptake time series data focusing on the United States.
The researchers found that the data were most consistent with the waning immunity model; by age 18 years, an estimated 32.8 percent of individuals had lost vaccine-derived immunity. The waning model reproduces features of the epidemiological data, including the shift in mumps incidence toward older individuals, recent recurrence of mumps outbreaks, and the high proportion of mumps cases among previously vaccinated individuals.
"We found that, due to the combination of waning immunity and primary vaccine failure, robust herd immunity cannot be achieved with the present vaccine and immunization schedule," the authors write. "Indeed, our results support, in principle, the administration of regular booster doses to achieve and maintain herd immunity."
Related Posts
COVID Infection May Boost Antibodies for Up to 20 Months
MONDAY, Feb. 7, 2022 (HealthDay News) -- If you've already had COVID-19, your...
Web Searches for ‘Self-Managed Abortion’ Rose After Dobbs Decision
WEDNESDAY, Sept. 13, 2023 (HealthDay News) -- When some U.S. states made...
¿Podría el ‘gen del Alzheimer’ aumentar el riesgo de una COVID-19 grave?
VIERNES, 31 de diciembre de 2021 (HealthDay News) -- Hace mucho que se sabe que...
Crisaborole Effective for Long-Term Maintenance in Mild-to-Moderate Eczema
WEDNESDAY, June 28, 2023 (HealthDay News) -- Crisaborole is effective as a...
